Abstract

Inflammatory bowel disease is a condition of acute and chronic inflammation of the gut. An important factor contributing to pathogenesis is a dysregulated mucosal immunity against commensal bacteria and fungi. Host pattern-recognition receptors (PRRs) sense commensals in the gut and are involved in maintaining the balance between controlled responses to pathogens and overwhelming innate immune activation. C-type lectin receptors (CLRs) are PRRs recognizing glycan structures on pathogens and self-antigens. Here we examined the role of the murine CLR specific intracellular adhesion molecule-3 grabbing non-integrin homolog-related 3 (SIGNR3) in the recognition of commensals and its involvement in intestinal immunity. SIGNR3 is the closest murine homolog of the human dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) receptor recognizing similar carbohydrate ligands such as terminal fucose or high-mannose glycans. We discovered that SIGNR3 recognizes fungi present in the commensal microbiota. To analyze whether this interaction impacts the intestinal immunity against microbiota, the dextran sulfate sodium-induced colitis model was employed. SIGNR3−/− mice exhibited an increased weight loss associated with more severe colitis symptoms compared to wild-type control mice. The increased inflammation in SIGNR3−/− mice was accompanied by a higher level of TNF-α in colon. Our findings demonstrate for the first time that SIGNR3 recognizes intestinal fungi and has an immune regulatory role in colitis.

Highlights

  • Inflammatory bowel disease (IBD) is a condition of acute and chronic inflammation and can be classified in ulcerative colitis (UC) and Crohn’s disease (CD)

  • A significantly higher interaction of SIGNR3-hFc to intestinal microbiota was detected compared with MGL1-hFc and dendritic cell immunoactivating receptor (DCAR)-hFc produced in the same way, or human Fc alone, indicating specificity of the SIGNR3-microbiota interaction

  • These findings show that SIGNR3 recognizes fungi in the microbiota presumably by binding to mannose-rich structures

Read more

Summary

Introduction

Inflammatory bowel disease (IBD) is a condition of acute and chronic inflammation and can be classified in ulcerative colitis (UC) and Crohn’s disease (CD). UC mainly affects the mucosal lining of the colon and rectum, whereas inflammation in CD occurs throughout the whole intestinal wall and may affect the whole gastrointestinal tract [1]. The mechanisms underlying these severe diseases are poorly understood. An imbalance of the mucosal immunity against intestinal microbiota plays an essential role in colitis induction [3, 4]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call